Roche Appeals Ranbaxy Noninfringement Ruling

Law360, New York (October 26, 2009, 6:45 PM EDT) -- Roche Palo Alto LLC has decided to appeal a ruling that while its patent for Valcyte is valid, a generic version of the anti-viral drug made by Ranbaxy Laboratories Ltd. does not infringe it.

The drugmaker lodged a notice of its appeal of the Sept. 30 ruling from Judge Freda Wolfson of the U.S. District Court for the District of New Jersey on Friday.

In a detailed 92-page order, Judge Wolfson said that Ranbaxy had failed to prove that the patent in question was invalid and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.